Z-2490-2019 Class III Terminated

Recalled by Randox Laboratories Ltd. — Crumlin (North)

FDA device recall Z-2490-2019 was initiated by Randox Laboratories Ltd. on Jul 12, 2019 and is designated Class III. Reason for recall: Randox Laboratories realigned RX Analyser Series calibration targets by 10% for AST and 9% for ALT in line with the Mean of All Instrument method target for the Randox Calibration Serum Level 3 (for… The recall status is terminated (terminated Jun 17, 2020). Affected quantity: 307 kits.

Recall details

Product Type
Devices
Report Date
Sep 18, 2019
Initiation Date
Jul 12, 2019
Termination Date
Jun 17, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
307 kits

Product description

This is an in vitro diagnostic product intended for use as a calibration serum in clinical chemistry assays. Randox calibration sera contain 42 analytes and are based on lyophilized human serum. The concentrations and activities are suitable for calibration of clinical chemistry assays both manually and on a wide range of automatic analyzers. Constituent concentrations are available at 2 levels.

Reason for recall

Randox Laboratories realigned RX Analyser Series calibration targets by 10% for AST and 9% for ALT in line with the Mean of All Instrument method target for the Randox Calibration Serum Level 3 (for calibrator lot 961UE onwards).

Distribution pattern

Nationwide Foreign: Antigua, Aruba, Bahamas, Granada, Tobago,

Code information

Lot Numbers: 961UE onwards GTN: 05055273200966

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2490-2019
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2490-2019. Report a data issue: hello@regdatalab.com.